Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer
- 31 December 2003
- journal article
- clinical trial
- Published by Elsevier in Brachytherapy
- Vol. 2 (2) , 77-84
- https://doi.org/10.1016/s1538-4721(03)00095-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTSJournal of Urology, 2002
- 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2001
- The Evolving Role of Prostate BrachytherapyCancer Control, 2001
- Real-time optimized intraoperative dosimetry for prostate brachytherapy: A pilot studyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARSJournal of Urology, 2000
- Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directionsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Prostate Cancer Clinical Guidelines Panel Summary Report on the Management of Clinically Localized Prostate CancerJournal of Urology, 1995